The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125439044 12543904 4 F 20160715 20160825 20160711 20160901 EXP BR-ALEXION PHARMACEUTICALS INC-A201605007 ALEXION 37.00 YR F Y 0.00000 20160901 CN BR BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125439044 12543904 1 PS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 900 MG, UNK 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION
125439044 12543904 2 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 1200 MG, EVERY 15 DAYS 125166 1200 MG CONCENTRATE FOR SOLUTION FOR INFUSION
125439044 12543904 3 C MYCOPHENOLATE MYCOPHENOLIC ACID 1 Unknown N 0
125439044 12543904 4 C TACROLIMUS. TACROLIMUS 1 Unknown N 0
125439044 12543904 5 C CIPROFLOXACIN. CIPROFLOXACIN 1 Unknown 0
125439044 12543904 6 C METRONIDAZOLE. METRONIDAZOLE 1 Unknown 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125439044 12543904 1 Haemolytic uraemic syndrome
125439044 12543904 3 Immunosuppression
125439044 12543904 4 Immunosuppression
125439044 12543904 5 Bacterial infection
125439044 12543904 6 Bacterial infection

Outcome of event

Event ID CASEID OUTC COD
125439044 12543904 HO
125439044 12543904 DE
125439044 12543904 OT
125439044 12543904 LT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125439044 12543904 Blood creatinine increased
125439044 12543904 Blood lactate dehydrogenase increased
125439044 12543904 Blood urea increased
125439044 12543904 Drug ineffective
125439044 12543904 Encephalitis
125439044 12543904 Haematocrit decreased
125439044 12543904 Haemoglobin decreased
125439044 12543904 Haptoglobin decreased
125439044 12543904 Kidney transplant rejection
125439044 12543904 Renal impairment
125439044 12543904 Septic shock
125439044 12543904 Shock
125439044 12543904 Thrombocytopenia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125439044 12543904 1 20160624 0
125439044 12543904 2 20160708 20160715 0